A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia (Q35830911)
Jump to navigation
Jump to search
scientific article published on 2 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia |
scientific article published on 2 December 2011 |
Statements
1 reference
A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia (English)
1 reference
H J Mackay
1 reference
R J Buckanovich
1 reference
H Hirte
1 reference
R Correa
1 reference
P Hoskins
1 reference
J Biagi
1 reference
L P Martin
1 reference
G F Fleming
1 reference
R Morgan
1 reference
L Wang
1 reference
R Polintan
1 reference
A M Oza
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference